TriSalus Life Sciences
TLSI
TLSI
53 hedge funds and large institutions have $139M invested in TriSalus Life Sciences in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
5.85% more ownership
Funds ownership: 51.77% → 57.62% (+5.8%)
Holders
53
Holding in Top 10
–
Calls
$63K
Puts
–
Top Buyers
| 1 | +$2.28M | |
| 2 | +$2.18M | |
| 3 | +$1.94M | |
| 4 |
JGC
J. Goldman & Co
New York
|
+$1.81M |
| 5 |
SV
Starboard Value
New York
|
+$1.46M |
Top Sellers
| 1 | -$1.36M | |
| 2 | -$966K | |
| 3 | -$240K | |
| 4 |
Morgan Stanley
New York
|
-$1.25K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |